Clinical Trial Update: Glucokinase Activator in Monogenic Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a glucokinase activator for monogenic diabetes is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Monogenic Diabetes

Drugs mentioned

• Glucokinase activator

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Diabetes Mellitus, Monogenic Diabetes | Phase 2 | Status: NOT_YET_RECRUITING